FindTrial
Sign In

A clinical trial to compare the effects of stopping phototherapy administered for newborn babies affected by jaundice at low and high serum bilirubin levels.

A comparison of two targets of serum bilirubin concentration for phototherapy discontinuation in neonatal jaundice.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011740
Enrollment
240
Registered
2018-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Neonatal jaundice

Interventions

Intervention1: Group A: Phototherapy will be stopped once serum bilirubin falls 1.0 to 2.9mg/dl below treatment threshold. Control Intervention1: Group B: Phototherapy will be stopped once serum bilir

Sponsors

Veda Senthil Velan Ganesan
Lead Sponsor
Ramesh S
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Babies with gestational age >=35 weeks, 2)Babies with birth weight >1800 grams, 3)Babies requiring phototherapy for the first time, 4)Babies with onset of jaundice <=7 days.

Exclusion criteria

Exclusion criteria: Babies planned for immediate exchange transfusion at the time of admission

Design outcomes

Primary

MeasureTime frame
Number of babies who require re-initiation of phototherapy.Timepoint: 24 hours after stopping phototherapy—

Secondary

MeasureTime frame
Total duration of phototherapy including treatment after rebound hyperbilirubinemia and total duration of hospital stay.Timepoint: Less than 7 days—

Countries

India

Contacts

Public ContactRamesh S

PSG Institute of Medical Sciences and Research

drsramesh95@gmail.com9962823975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026